WallStreetZenWallStreetZen

NASDAQ: IMPL
Impel Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their IMPL stock forecasts and price targets.

Forecast return on equity

Is IMPL forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is IMPL forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.29%

IMPL revenue growth forecast

How is IMPL forecast to perform vs Biotechnology companies and vs the US market?
Company
95.61%
Industry
34.65%
Market
7.68%
IMPL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IMPL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IMPL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IMPL$0.41N/AN/A
BCLI$0.20N/AN/A
ONVO$1.11N/AN/A
GOVX$0.36$8.00+2,122.22%Buy
PSTV$2.12$8.00+277.36%Buy

Impel Pharmaceuticals Stock Forecast FAQ

What is IMPL's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: IMPL) forecast ROE is N/A, which is considered weak.

If you're new to stock investing, here's how to buy Impel Pharmaceuticals stock.

What is IMPL's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: IMPL) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.29%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.